Skip to main content
Skip to main content
JCNCX logo

Janus Henderson Contrarian Fund (JCNCX) Fund Overview

Educational signal · not a buy or sell recommendation · How to read this

$26.25 -$0.58 (-2.16%)

Beta 1.35: the stock has moved about 35% more than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Janus Henderson Contrarian Fund (JCNCX) trades at $26.25. Janus Henderson Contrarian Fund is a non-diversified fund focused on long-term capital growth through investments in undervalued equity securities. Sector: Financial services.

Price as of Sep 10, 2026 · Last analyzed: Mar 17, 2026
Janus Henderson Contrarian Fund is a non-diversified fund focused on long-term capital growth through investments in undervalued equity securities. The fund invests in companies of all sizes, seeking those trading at a discount to their fair value.

Analyst Coverage for JCNCX: JCNCX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates JCNCX against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the JCNCX film Every key number, told as a short cinematic story — just press play. ~2 min

Janus Henderson Contrarian Fund (JCNCX) Financial Services Profile

HeadquartersDenver, US
IPO Year2005

Janus Henderson Contrarian Fund (JCNCX) is a non-diversified asset management fund seeking long-term capital appreciation by investing in undervalued equity securities across market capitalizations. The fund's contrarian approach aims to identify companies trading below their intrinsic value within the broader financial services sector.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for JCNCX?

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Janus Henderson Contrarian Fund's investment thesis centers on the principle of value investing, targeting companies whose stock prices are below their estimated fair value. The fund's success hinges on the manager's ability to accurately assess intrinsic value and identify catalysts that will drive market recognition of this value. A key driver is the fund's non-diversified approach, allowing for concentrated positions in high-conviction ideas. However, this also introduces higher volatility. The fund's performance is closely tied to the overall market sentiment and the ability of undervalued companies to realize their potential. Investors should monitor the fund's holdings and the manager's track record in identifying and capitalizing on contrarian investment opportunities. The fund's beta of 1.35 suggests higher volatility compared to the market.

Based on FMP financials and quantitative analysis

JCNCX Key Highlights

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

The fund invests at least 80% of its net assets in equity securities.

  • The fund is non-diversified, allowing for concentrated positions.
  • The investment strategy focuses on companies trading at a discount to their fair value.
  • The fund invests in companies of any size, from large-cap to small-cap.
  • The fund's beta is 1.35, indicating higher volatility than the market.

Who Are JCNCX's Competitors?

JCNCX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
BEGRX Franklin Mutual Beacon Fund $19.95 -0.94% $3.40B
CCFAX American Funds College 2036 Fund $14.57 +0.21% $3.88B
JDPNX Janus Henderson Mid Cap Value Fund $16.42 -1.02% $3.66B
BLK BlackRock, Inc. $1086.96 +2.31% $168B 495-pillar
BX Blackstone Inc. $129.75 +3.46% $157B 705-pillar
BAM Brookfield Asset Management $47.24 -1.01% $75.4B 575-pillar
APOS Apollo Global Management, Inc. $25.29 +0.04% $74.0B 545-pillar
AMP Ameriprise Financial, Inc. $551.72 -0.33% $49.6B 725-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are JCNCX's Key Strengths?

Experienced fund management team.

  • Contrarian investment approach.
  • Focus on undervalued companies.
  • Non-diversified portfolio allows for concentrated positions.

What Are JCNCX's Weaknesses?

Non-diversified portfolio can lead to higher volatility.

  • Performance is dependent on the manager's ability to identify undervalued companies.
  • Contrarian approach may underperform in strong bull markets.
  • Fund is susceptible to market sentiment and investor behavior.

What Could Drive JCNCX Stock Higher?

Successful identification and investment in undervalued companies.

  • Positive market sentiment towards value investing.
  • Potential economic recovery driving growth in undervalued sectors.
  • Changes in regulatory environment favoring active management strategies.

What Are the Key Risks for JCNCX?

Market volatility impacting the value of the fund's holdings.

  • Inability to accurately identify and capitalize on undervalued companies.
  • Underperformance relative to benchmark index.
  • Changes in investor sentiment towards value investing.
  • Non-diversified portfolio leading to higher risk.

What Are the Growth Opportunities for JCNCX?

  • Expansion into new sectors: The fund could explore investment opportunities in sectors currently underrepresented in its portfolio, such as technology or healthcare, to diversify its holdings and capture potential growth in these areas. This would require the fund manager to develop expertise in these sectors and identify undervalued companies with strong growth prospects. The timeline for this expansion would depend on market conditions and the availability of suitable investment opportunities. The global healthcare market is projected to reach $380 billion by 2028, presenting a significant growth opportunity.
  • Increased focus on small-cap companies: The fund could increase its allocation to small-cap companies, which often have higher growth potential than larger, more established companies. This would require a more active approach to stock selection and a greater tolerance for risk. The timeline for this shift would depend on the fund manager's assessment of the small-cap market and the availability of attractive investment opportunities. The Russell 2000 index, which tracks small-cap companies, has historically outperformed the S&P 500 over long periods.
  • Development of ESG-focused investment strategies: The fund could incorporate environmental, social, and governance (ESG) factors into its investment decision-making process to attract socially conscious investors. This would require the fund manager to develop a framework for evaluating companies based on their ESG performance. The timeline for this integration would depend on the fund manager's commitment to ESG investing and the availability of reliable ESG data.
  • Leveraging technology for enhanced analysis: The fund could adopt advanced data analytics and artificial intelligence (AI) tools to improve its stock selection process and identify undervalued companies more efficiently. This would require investment in technology infrastructure and the development of expertise in data science. The timeline for this implementation would depend on the fund's resources and the availability of suitable technology solutions. The adoption of AI in asset management is expected to increase significantly in the coming years, driven by the potential for improved investment performance.
  • Geographic diversification: The fund could expand its investment universe to include companies in emerging markets, which often have higher growth rates than developed markets. This would require the fund manager to develop expertise in these markets and navigate the associated risks. The timeline for this expansion would depend on the fund manager's assessment of the emerging markets and the availability of attractive investment opportunities. Emerging markets are projected to contribute significantly to global economic growth in the coming years, presenting a potential growth opportunity for the fund.

What Threats Does JCNCX Face?

  • Increased competition from passive investment strategies.
  • Market volatility and economic uncertainty.
  • Regulatory changes and compliance costs.
  • Loss of key personnel.

What Are JCNCX's Competitive Advantages?

  • Established brand name and reputation within the asset management industry.
  • Experienced fund management team with a proven track record.
  • Proprietary investment process for identifying undervalued companies.

What Does JCNCX Do?

Janus Henderson Contrarian Fund (JCNCX) is an actively managed, non-diversified fund within the Janus Henderson Investors group. The fund's core strategy revolves around identifying and investing in equity securities that are perceived to be trading at a significant discount to their intrinsic or fair value. This contrarian approach seeks to capitalize on market inefficiencies and investor sentiment, aiming for long-term capital appreciation. The fund was established with the objective of providing investors access to a portfolio of companies believed to have substantial growth potential that is not currently reflected in their stock prices. JCNCX is not constrained by market capitalization, allowing the fund manager to invest in a range of companies, from large, well-established corporations to smaller, emerging growth businesses. The fund operates primarily within the equity markets, focusing on companies with the potential for long-term growth.

What Products and Services Does JCNCX Offer?

  • Invests in equity securities with long-term growth potential.
  • Focuses on companies trading at a discount to their fair value.
  • Invests in companies of any size, from large to small.
  • Manages a non-diversified portfolio.
  • Seeks to achieve long-term capital appreciation.
  • Conducts fundamental analysis to identify undervalued companies.
  • Actively manages the portfolio based on market conditions and company performance.

How Does JCNCX Make Money?

  • Generates revenue through management fees charged on assets under management (AUM).
  • Aims to increase AUM by attracting new investors and retaining existing ones.
  • Seeks to outperform its benchmark index to attract and retain investors.

What Industry Does JCNCX Operate In?

Janus Henderson Contrarian Fund operates within the asset management industry, which is characterized by intense competition and evolving investor preferences. The industry is influenced by macroeconomic factors, market volatility, and regulatory changes. The rise of passive investing and the increasing demand for specialized investment strategies are reshaping the competitive landscape. JCNCX differentiates itself through its contrarian approach and focus on undervalued companies. Competitors include funds with similar investment objectives, such as BEGRX, CCFAX, JDPNX, JDPRX, and JMVAX. The asset management industry is projected to experience continued growth, driven by increasing global wealth and the need for retirement planning.

Who Are JCNCX's Key Customers?

  • Individual investors seeking long-term capital appreciation.
  • Institutional investors, such as pension funds and endowments.
  • Financial advisors recommending investment products to their clients.
Model self-rating on this text: 81% (not a measure of the evidence) Updated: Mar 17, 2026

Research confidence

Low 20/100

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • Scoring coverage unknown
  • Price is current
  • No filing on record
  • No analyst coverage
  • This is a fund, not an operating company

MoonshotScore History

Recorded daily since 2026-08-23 · 20 snapshots

2026-08-23 44
2026-08-27 44
2026-08-31 44
2026-09-04 44
2026-09-08 44
2026-09-11 44

What changed?

The score has stayed at 44.

Over the same 19 days the stock moved -3.1%.

JCNCX Financials

Bull Case vs Bear Case

Bull Case

  • Experienced fund management team.
  • Contrarian investment approach.
  • Focus on undervalued companies.
  • Non-diversified portfolio allows for concentrated positions.

Bear Case

  • Non-diversified portfolio can lead to higher volatility.
  • Performance is dependent on the manager's ability to identify undervalued companies.
  • Contrarian approach may underperform in strong bull markets.
  • Fund is susceptible to market sentiment and investor behavior.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

JCNCX Latest News

No recent news available for JCNCX.

JCNCX Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for JCNCX.

Price Targets

Wall Street price target analysis for JCNCX.

JCNCX MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for JCNCX; grades run from A+ (80-100) to F (below 30).

Janus Henderson Contrarian Fund ADR Information Sponsored

An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. JCNCX, while managed in the US, invests in companies that may be based internationally. As an ADR, it simplifies investing in these companies for U.S. investors by handling currency conversion and other complexities.

  • Home Market Ticker: Denver, US
  • ADR Level: 2
  • ADR Ratio: 1:1
Currency Risk: As an ADR, JCNCX is subject to currency risk. The fund's investments in foreign companies are denominated in their local currencies. Fluctuations in exchange rates between the U.S. dollar and these currencies can impact the fund's performance, either positively or negatively. Investors should be aware of this potential risk.
Tax Implications: Dividends paid on ADRs are generally subject to foreign withholding taxes in the country of origin. The specific withholding tax rate varies depending on the country and any applicable tax treaties between the U.S. and that country. U.S. investors may be able to claim a foreign tax credit on their U.S. tax return for the amount of foreign taxes withheld.
Trading Hours: Since JCNCX is managed in the US, there are no trading hour differences. The fund is traded during standard US market hours. However, the underlying assets may be traded in different time zones.

JCNCX Financial Services Stock FAQ

Is JCNCX a good stock?

Stock Expert AI does not rate JCNCX buy, sell or hold. Janus Henderson Contrarian Fund has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

How does JCNCX's contrarian strategy affect its performance in different market cycles?

JCNCX's contrarian strategy aims to outperform over the long term by identifying and investing in undervalued companies that the market has overlooked. In bull markets, the fund may underperform as investors chase high-growth stocks, leaving value stocks behind.

What are the key factors to evaluate for JCNCX?

Evaluate JCNCX on fundamentals, analyst consensus, and risk factors. The fund's beta of 1.35 suggests higher volatility compared to the market. Not financial advice.

How frequently does JCNCX data refresh on this page?

JCNCX's price was last updated on Sep 10, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 calculations are scheduled daily at 10:15 UTC; the score's own date shows its last successful run.

What has driven JCNCX's recent stock price performance?

Janus Henderson Contrarian Fund (JCNCX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Experienced fund management team. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider JCNCX overvalued or undervalued right now?

Janus Henderson Contrarian Fund (JCNCX) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of JCNCX?

Yes, most major brokerages offer fractional shares of Janus Henderson Contrarian Fund (JCNCX) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track JCNCX's earnings and financial reports?

Janus Henderson Contrarian Fund (JCNCX) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for JCNCX earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is limited to market cap and beta.
  • Analyst consensus is unavailable.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover